Are generic GLP-1 medications available?

No true generic GLP-1 medications are currently available due to patent protection and complex biologic manufacturing. Semaglutide formulations are protected by patents extending to 2031-2032, tirzepatide through the mid-2030s. However, compounded semaglutide offers a lower-cost alternative available from 503A and 503B compounding pharmacies. These aren't generics but pharmacy-prepared versions using the same active pharmaceutical ingredient as brand names. Compounded semaglutide costs $200-500 monthly compared to $1,300-1,600 for brand names. Quality varies by pharmacy, so choosing reputable compounders is essential. Biosimilar versions (similar to generics for biologics) may enter the market when patents expire, though the technical complexity of manufacturing GLP-1s may delay widespread generic availability for several years post-patent. For now, options for cost reduction include: insurance coverage, manufacturer copay cards, patient assistance programs, compounded versions, and Mark Cuban's Cost Plus Drugs. Check the FDA's Orange Book for patent expiration dates and generic availability updates.